In depth view into Cara Therapeutics Total Employees (Annual) including historical data from 2014, charts, stats and industry comps. The stock options were granted as inducement material to each new employee entering into employment with Cara in accordance with Nasdaq Listing Rule 5635(c)(4). 11 May 2020 Cara Therapeutics Reports First Quarter 2020 Financial Results. Cara Therapeutics stock-based compensation from 2012 to 2019.
For Example: Lot 1 will start to close at 10:00 AM, Lot 2 will start to close at 10:01 AM and so forth. Health Care . Cara Therapeutics – Lot Catalog. NewsSee all news. (On the day the auction is set to close, each lot will clearly countdown the time left until closing.) Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. As of 08:00 PM EDT 05/18/2020 . SECTOR. SEE QUOTE. … Lot Closings: Lot Closings: The Lots will have a staggered closing time with 1 closing every minute in numerical order. Cara Therapeutics serves customers in the United States. Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to … CARA:US 15.07 USD +0.03 +0.20%. CURRENT PRICE. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors STAMFORD, Conn., May 11, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by